Chronic Kidney Disease

The AJMC^® Chronic Kidney Disease compendium is a comprehensive resource for clinical news and expert insights on the condition and treatment of loss of kidney function.

Latest News

Viet Le, PA-C, Intermountain Health

Fostering Interdisciplinary Communication: How Cardio-Renal-Metabolic Care Models Optimize Care Delivery

October 19th 2024

Viet Le, PA-C, Intermountain Health, gives insights into the benefits cardio-renal-metabolic care models provide for patients in need.

Navdeep Tangri, MD, PhD, FRCP

Population Health Strategies Are Vital for Tackling, Improving CKD Care

October 18th 2024

Value-based care calls for long-term thinking about sustained benefit | image credit: momius - stock.adobe.com

Long-Term Benefits Show the Value of Upfront Investments in Value-Based Care

October 17th 2024

AJMC

Identifying Chronic Kidney Disease Stage 3 With Excess Disease Burden

By Austin Campbell, PhD
Lihao Chu, PhD

June 24th 2024

AJMC

Defragmentation of Care in Complex Patients With ESKD Improves Clinical Outcomes

By Nathan Moore, MD
David Roer, MD

May 13th 2024

Population Health Management of Chronic Kidney Disease (CKD)

An expert panel discusses chronic kidney disease (CKD), its impact on cardiovascular disease, and the methods of treatment used on the patient populations.

Panel members

More News

June 12th 2019

More CV, Renal Outcomes at ADA: CREDENCE, CARMELINA, CAROLINA

The final morning session of the 79th Scientific Sessions of the American Diabetes Association (ADA) in San Francisco, California, featured more cardiovascular and renal results from recent trials involving type 2 diabetes drugs.

June 11th 2019

Highlighting Links Between Kidney, CV Disease in Diabetes

The connections among diabetes, cardiovascular (CV) disease, and kidney failure have been a theme of the 79th Scientific Sessions of the American Diabetes Association, which featured a joint session with the American Society of Nephrology.

CREDENCE Results for Canagliflozin to Be Presented This Weekend in Australia

April 11th 2019

CREDENCE Results for Canagliflozin to Be Presented This Weekend in Australia

The findings represent the first in a new wave of renal outcomes trials in the sodium glucose co-transporter 2 (SGLT2) inhibitor class, a game-changing group of type 2 diabetes drugs with many benefits beyond lowering blood glucose.

5 Takeaways From the 2019 American College of Cardiology Meeting

March 22nd 2019

5 Takeaways From the 2019 American College of Cardiology Meeting

For SGLT2 inhibitors and a fish oil capsule, there was plenty of good news; for aspirin, not so much. A recap of the American College of Cardiology's 68th Annual Scientific Session, held March 16-18, 2019, in New Orleans, Louisiana.

September 26th 2018

Clinical Outcomes and Healthcare Use Associated With Optimal ESRD Starts

Peter W. Crooks, MD Christopher O. Thomas, MD Amy Compton-Phillips, MD Wendy Leith, MS, MPH Alvina Sundang, MBA Yi Yvonne Zhou, PhD Linda Radler, MBA

Optimal end-stage renal disease (ESRD) starts were associated with lower 12-month morbidity, mortality, and inpatient and outpatient utilization in an integrated healthcare delivery system.

April 16th 2018

A Payer–Provider Partnership for Integrated Care of Patients Receiving Dialysis

Justin Kindy, FSA, MAAA David Roer, MD Robert Wanovich, PharmD Stephen McMurray, MD

A report on the clinical and economic outcomes of a new payer–provider partnership serving patients with end-stage renal disease.

April 4th 2018

Physician and Patient Tools to Improve Chronic Kidney Disease Care

Thomas D. Sequist, MD, MPH Alison M. Holliday, MPH E. John Orav, PhD David W. Bates, MD, MSc Bradley M. Denker, MD

Decision support tools, disease registries, and patient engagement materials can improve population-based chronic kidney disease care.

November 15th 2017

Researchers Dig Deeper on SGLT2 Inhibitors and Find Plenty of News

Researchers presenting at the American Heart Association look at specific populations within 2 large diabetes drug trials, CANVAS and EMPA-REG OUTCOME.

August 31st 2017

Liraglutide Improves Renal Outcomes in Type 2 Diabetes Patients With CV Risk

The study finds that the GLP-1 receptor agonist can slow progression of kidney disease, one of the most costly and debilitating complications of type 2 diabetes.

July 20th 2017

From Unexpected CV Benefits to Potential in Heart Failure: Insights and Outlook for SGLT2 Inhibitors

Coverage from the first of 3 Peer Exchangeâ„¢ discussions from the Diabetes Stakeholders Summit.

February 9th 2017

Safety Nets for Undocumented Immigrants With ESRD Fall Short

Christina Mattina

A recent investigation into the experiences of undocumented Hispanic immigrants with end-stage renal disease reveals that their inability to access regular dialysis can have devastating physical and emotional ramifications.

June 16th 2016

Effects of Physician Payment Reform on Provision of Home Dialysis

Kevin F. Erickson, MD, MS Wolfgang C. Winkelmayer, MD, ScD Glenn M. Chertow, MD, MPH Jay Bhattacharya, MD, PhD

The Medicare program’s transition in 2004 to tiered fee-for-service physician reimbursement for dialysis care had the unintended consequence of reducing use of home dialysis.

January 25th 2016

Why Is Dialysis Starting Earlier? Are Patients Being Heard?

Researchers found that physicians often seized the "opportunity" to start dialysis if patients were in the hospital for other illnesses.

March 21st 2014

Medicaid Expansion May Help Prevent Kidney Failure, Improve Access to Kidney-Related Care

States with broader Medicaid coverage have lower incidences of kidney failure and smaller insurance-related gaps in access to kidney disease care.

March 3rd 2014

Coalition Offers Broad Framework to Improve Kidney Care

A coalition of patient advocates, dialysis-care providers and manufacturers today will unveil a comprehensive new framework for kidney care across the country that identifies four goals: improve survival, reduce hospitalizations, improve health-related quality of life, and improve patient experience with care.

August 6th 2013

CMS Announces Changes to Dialysis ACO Application

The Centers for Medicare & Medicaid Services Innovation Center held an Open Door Forum on Aug. 1 to announce some modifications to the application for the Comprehensive ESRD Initiative, or renal-specific Accountable Care Organization demonstration.

...

7 8 9 10 11 12 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions